In-silico predicting as a tool to develop plant-based biomedicines and nanoparticles: Lycium shawii metabolites

Abstract

Combining in vitro studies and in silico molecular target prediction helps find novel therapeutic agents. Among L. shawii metabolites, emodin is suggested for further studies as an agent for drug development against pathogenic bacteria and cancer.